The Latest Breaking News from CVS Health

The Dow Jones Industrial Average rallied Thursday, looking to rebound from Wednesday's sharp losses. Treasury yields continued higher.

The stock market has been volatile lately amid investors’ anticipation of Federal Reserve interest rate hikes, skyrocketing inflation, supply chain disruptions, and a war between Russia and Ukraine. However, investing in companies with strong fundamentals and impressive growth prospects could help hedge market risks. So, we think it could be…

CVS Health is the IBD Stock of the Day. The pharmacy operator is offering investors two buying opportunities. CVS stock rose Tuesday.

Someone with a lot of money to spend has taken a bearish stance on CVS Health (NYSE:CVS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

More than half of all Americans say they've directly felt the effects of health care worker shortages, from canceled appointments to delayed surgeries, according to results from a CVS Health-Harris Poll National Health project provided to Axios.

Within the last quarter, CVS Health (NYSE:CVS) has observed the following analyst ratings:

One of the most common questions traders have about stocks is “Why Is It Moving?”

CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 3.35% on an annualized basis.

According to Benzinga Pro data CVS Health (NYSE:CVS) posted a 18.34% decrease in earnings from Q3. Sales, however, increased by 3.81% over the previous quarter to $76.60 billion.